Pfizer's concerted effort to move beyond its pandemic-era business and establish a new growth foundation in oncology faced an unexpected challenge this week. A revelation concerning regulatory ...

Metsera has several potential big winners in its pipeline, but the most promising might be its experimental obesity drugs MET ...

Panelists at this month's Microsoft Ignite event talked about their efforts to roll out agentic AI at their companies, ...

Jefferies London Healthcare Conference 2025 November 19, 2025 4:00 AM ESTCompany ParticipantsDavid Denton - Executive VP ...

NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind ...

A group of Hispanic residents are fearing for their safety after losing important documents in an apartment fire on the city's North Side Tuesday afternoon. Trump calls Nancy Pelosi 'evil woman' after ...

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera. Novo is now offering to pay as much as $10 billion for the company, Metsera ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of ...